SPL — Starpharma Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- AU$357.79m
- AU$347.48m
- AU$12.05m
Annual cashflow statement for Starpharma Holdings, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 8.33 | 8.34 | 8.78 | 6.5 | 4.3 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -13.2 | -13.5 | -6.98 | -6.76 | -3.21 |
| Capital Expenditures | -0.837 | -0.621 | -0.089 | -0.042 | -0.287 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.001 | 0.011 | 0 | — | 0.028 |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.836 | -0.61 | -0.089 | -0.042 | -0.259 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.23 | -0.695 | -4.75 | -1.13 | -0.876 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.6 | -14.7 | -11.8 | -7.95 | -4.39 |